Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
49
Participants
Timeline
Start Date
March 31, 2002
Primary Completion Date
January 31, 2007
Study Completion Date
April 30, 2009
Conditions
CholangiocarcinomaGallbladder Cancer
Interventions
DRUG
Gemcitabine
DRUG
Carboplatin
Trial Locations (1)
63110
Washington University School of Medicine, St Louis
All Listed Sponsors
lead
Washington University School of Medicine
OTHER
NCT00660140 - Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer | Biotech Hunter | Biotech Hunter